The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2011
DOI: 10.1016/j.ijom.2011.01.009
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
15
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 21 publications
0
15
0
Order By: Relevance
“…In their study of massive macrocystic lymphatic malformations, Chen et al observed excellent outcomes with a combination of fibrin glue, OK-432 and bleomycin in 53% of patients, in comparison to good and partial outcomes in 33% and 13% of cases, respectively. 19 None of the patients required surgical excision. 19 Thyroglossal duct cysts account for 70% of congenital neck masses; these lesions have a bimodal age distribution in which 90% of patients present by the age of 10 years, with a second peak in young adulthood.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In their study of massive macrocystic lymphatic malformations, Chen et al observed excellent outcomes with a combination of fibrin glue, OK-432 and bleomycin in 53% of patients, in comparison to good and partial outcomes in 33% and 13% of cases, respectively. 19 None of the patients required surgical excision. 19 Thyroglossal duct cysts account for 70% of congenital neck masses; these lesions have a bimodal age distribution in which 90% of patients present by the age of 10 years, with a second peak in young adulthood.…”
Section: Discussionmentioning
confidence: 99%
“…19 None of the patients required surgical excision. 19 Thyroglossal duct cysts account for 70% of congenital neck masses; these lesions have a bimodal age distribution in which 90% of patients present by the age of 10 years, with a second peak in young adulthood. 4 Surgery in the form of a classic Sistrunk procedure is the preferred method of management.…”
Section: Discussionmentioning
confidence: 99%
“…Bleomycin, a glucopeptide produced by Streptomyces Verticilus, which acts by breaking DNA chains with free radicals, affects tumor cells. Its side effects are erythema, edema, pain, local necrosis and flagellate hyperpigmentation (resolves with drug interruption) 14 .…”
Section: Discussionmentioning
confidence: 99%
“…Combined aspiration and compression is not always an effective treatment for the high rate of recurrence. Sclerosant agents cause fibrosis and obliteration of both lymphocele and ruptured lymphatic vessel, damaging the lymphatic drainage. The same side effect happens when performing macroscopic ligation of subcutaneous tissue containing lymphatic vessels.…”
Section: Discussionmentioning
confidence: 99%
“…Even sclerotherapy has been proposed and since Teruel reported first succesful case, employing povidone iodine for lymphocele, a lot of sclerosant agents have been used, mainly for pelvic, but even for subcutaneous lymphocele, such as bleomycin, OK‐432, polidocanol, sodium tetradecyl solfato, sodio azetroato, fibrin glue, etanol, and tetracicline. This therapy has the advantage of being very simple but the drawback is that these agents act by strong inflammation of lymphocele walls and lymphatic vessel, causing fibrosis and obliteration of both . Surgical treatment can consist in reexploration of the lymphocele and ligation of subcutaneous tissue where lymphatic vessels are presumed to be, without direct microscopic visualization.…”
mentioning
confidence: 99%